(0)サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1699184

In Vivo毒性学市場の分析と2034年までの予測：タイプ、製品、サービス、技術、コンポーネント、用途、材料タイプ、エンドユーザー、段階

In Vivo Toxicology Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Material Type, End User, Stage

出版日
ページ情報
英文 462 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.32円
In Vivo毒性学市場の分析と2034年までの予測：タイプ、製品、サービス、技術、コンポーネント、用途、材料タイプ、エンドユーザー、段階
出版日: 2025年04月01日
発行: Global Insight Services
ページ情報: 英文 462 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

In Vivo毒性学市場は、2024年の62億米ドルから2034年には94億米ドルに拡大し、CAGR約4.2％で成長すると予測されています。同市場は、主に動物モデルを用いた、生体に対する物質の悪影響の研究を包含します。医薬品開発、化学的安全性、規制遵守にとって極めて重要です。バイオテクノロジーの進歩、医薬品研究開発の増加、厳格な安全規制が市場を牽引しています。代替検査法の革新と倫理的配慮が市場力学を形成し、より予測的で人道的な検査アプローチの開発を促進しています。

市場概要

In Vivo毒性学市場は、主に製薬・バイオテクノロジーセグメントの前臨床検査需要の増加に牽引され、堅調な拡大を続けています。市場を独占しているのはげっ歯類ベースのセグメントであり、その主要理由は、毒性検査におけるげっ歯類の広範な使用と、確立されたプロトコルの利用可能性です。げっ歯類、特にマウスとラットは、ヒトと遺伝的に類似していることと、その使用を裏付ける過去のデータが豊富であることから好まれています。このセグメントの優位性は、医薬品承認プロセスにおいて動物実験を義務付ける規制要件によってさらに強化されています。ゼブラフィッシュや非哺乳類モデルなどの新しいサブセグメントは、費用対効果や倫理的な利点から注目を集めています。これらのサブセグメントは、迅速な発達に関する洞察と高性能・スクリーニング能力を提供し、初期段階の創薬や環境毒性評価に変革をもたらす可能性があります。技術の進歩により、In Vivo検査の精度と倫理的配慮が強化され続けているため、これらの新興モデルは市場環境に大きな影響を与え、イノベーションを促進し、用途を拡大する態勢が整っています。

市場セグメンテーション
タイプ 急性毒性検査、慢性毒性検査、亜慢性毒性検査、発生・生殖毒性検査、発がん性検査
製品 機器、動物モデル、試薬、キット
サービス コンサルティングサービス、前臨床検査サービス
技術 CRISPR、RNA干渉、高性能スクリーニング
コンポーネント ソフトウェア、ハードウェア
用途 医薬品、バイオテクノロジー、化粧品、食品産業、化学産業
材料タイプ バイオ、化学
エンドユーザー 研究機関、受託研究機関、製薬会社、バイオテクノロジー企業
段階 探索、前臨床、臨床、市販後調査

In Vivo毒性学市場は、製薬とバイオテクノロジーセクターの影響が大きく、化学と食品産業からの寄与も大きいです。この状況は、包括的な安全性評価と規制遵守に対する需要の高まりによって形成されています。北米は先進的な研究インフラと規制の枠組みにより主導的な地位を維持しており、アジア太平洋は医薬品開発と研究革新への投資の増加により大幅な成長を遂げています。産業大手は、戦略的提携や検査手法の技術的進歩を通じて市場での存在感を高めています。競合の力学は、厳しい規制要件と動物使用を減らすための代替検査法の追求によって影響を受けています。FDAやEMAのような規制機関がそのような技術革新を提唱していることもあり、企業はより予測的で人道的な毒性学的モデルの開発に注力しています。CRISPRやorgan-on-a-chipのような技術の進歩は、従来の検査パラダイムに革命を起こすと期待されており、市場の将来的な軌道は有望に見えます。しかし、倫理的な懸念や先端技術の高コストといった課題も残っており、継続的な技術革新と投資が必要となっています。

主要動向と促進要因

In Vivo毒性学市場は、バイオテクノロジーと製薬研究の進歩に後押しされて成長を遂げています。主要動向は、精密医療が重視されるようになったことであり、そのためには、オーダーメイド治療の安全性を確保するための包括的な毒性学的評価が必要です。規制機関はモニタリングを強化しており、より厳格なIn Vivo検査プロトコルの需要を促進しています。CRISPRや先進的イメージング技術などの新たな技術は、毒物学的研究の精度と効率を高めています。こうした技術革新は医薬品開発にかかる時間とコストを削減し、市場開拓に有利な機会をもたらしています。慢性疾患の増加とそれに伴う創薬イニシアチブの急増は、この市場の実質的な促進要因です。さらに、動物実験を減らし、倫理基準や国民感情に沿った代替手法への注目も高まっています。これには、In Vivo検査を補完する先進的in vitroモデルの開発も含まれます。こうしたセグメントに投資する企業は、競争上の優位性を獲得する可能性が高いです。医療インフラと研究に対する世界の投資の増加は、特に医療の近代化が優先課題となっている新興国市場での市場拡大をさらに後押ししています。

抑制要因と課題

In Vivo毒性学市場には、いくつかの顕著な抑制要因と課題があります。重要な課題のひとつは、動物実験をめぐる倫理的な懸念であり、これが規制当局のモニタリングを強化し、代替検査法の開発につながっています。この変化により、研究と適応に多額の投資が必要となり、中小企業にとっては障壁となっています。さらに、専門施設と熟練した人材が必要なため、In Vivo検査には高いコストがかかり、新興市場や小規模企業にとっては利用しにくいものとなっています。生物学的システムの複雑さは、結果の解釈をさらに複雑にし、先進的専門知識を必要とし、一貫性のない結果につながる可能性があります。さらに、地域によって異なる厳しい規制要件は、製品の承認を遅らせ、コンプライアンス・コストを増大させる可能性があります。最後に、より予測的でヒトに関連したモデルに対する需要が高まっており、これは従来のIn Vivoの方法論に課題をもたらし、継続的な技術革新と検証の努力を必要とします。これらの要因は総体的に、In Vivo毒性学市場の急速な発展を妨げています。

目次

第1章 In Vivo毒性学市場概要

  • 調査目的
  • In Vivo毒性学市場の定義と調査範囲
  • レポートの制限事項
  • 調査対象年と通貨
  • 調査手法

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 In Vivo毒性学市場展望

  • In Vivo毒性学市場のセグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 4Pモデル
  • ANSOFFマトリックス

第5章 In Vivo毒性学市場戦略

  • 親市場分析
  • 需給分析
  • 消費者の購買意欲
  • 使用事例分析
  • 価格分析
  • 規制状況
  • サプライチェーン分析
  • 競合製品分析

第6章 In Vivo毒性学市場規模

  • In Vivo毒性学の市場規模：金額別
  • In Vivo毒性学の市場規模：数量別

第7章 In Vivo毒性学市場：タイプ別

  • 市場概要
  • 急性毒性検査
  • 慢性毒性検査
  • 亜慢性毒性検査
  • 発生・生殖毒性検査
  • 発がん性検査
  • その他

第8章 In Vivo毒性学市場：製品別

  • 市場概要
  • 機器
  • 動物モデル
  • 試薬とキット
  • その他

第9章 In Vivo毒性学市場：サービス別

  • 市場概要
  • コンサルティングサービス
  • 前臨床検査サービス
  • その他

第10章 In Vivo毒性学市場：技術別

  • 市場概要
  • CRISPR
  • RNA干渉
  • 高性能スクリーニング
  • その他

第11章 In Vivo毒性学市場：コンポーネント別

  • 市場概要
  • ソフトウェア
  • ハードウェア
  • その他

第12章 In Vivo毒性学市場：用途別

  • 市場概要
  • 医薬品
  • バイオテクノロジー
  • 化粧品
  • 食品産業
  • 化学産業
  • その他

第13章 In Vivo毒性学市場：材料タイプ別

  • 市場概要
  • バイオ
  • 化学品
  • その他

第14章 In Vivo毒性学市場：エンドユーザー別

  • 市場概要
  • 研究機関
  • 受託研究機関
  • 製薬会社
  • バイオテクノロジー企業
  • その他

第15章 In Vivo毒性学市場：段階別

  • 市場概要
  • 探索
  • 前臨床
  • 臨床検査
  • 市販後調査
  • その他

第16章 In Vivo毒性学市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • オランダ
    • スウェーデン
    • スイス
    • デンマーク
    • フィンランド
    • ロシア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • シンガポール
    • インドネシア
    • 台湾
    • マレーシア
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他の中東・アフリカ

第17章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業のポジショニング
  • 競合リーダーシップマッピング
  • ベンダーベンチマーキング
  • 開発戦略のベンチマーキング

第18章 企業プロファイル

  • Charles River Laboratories
  • Envigo
  • Taconic Biosciences
  • Harlan Laboratories
  • Genoway
  • Crown Bioscience
  • The Jackson Laboratory
  • TransCure bioServices
  • Inotiv
  • Biomere
  • Vivo Bio Tech
  • Pharmaron
  • Syngene International
  • Labcorp Drug Development
  • WuXi AppTec
  • Cyagen Biosciences
  • ChemPartner
  • Eurofins Scientific
  • Toxikon
  • Biocytogen
目次
Product Code: GIS20850

In Vivo Toxicology Market is anticipated to expand from $6.2 billion in 2024 to $9.4 billion by 2034, growing at a CAGR of approximately 4.2%. The market encompasses the study of adverse effects of substances on living organisms, primarily using animal models. It is pivotal for drug development, chemical safety, and regulatory compliance. The market is driven by advancements in biotechnology, increasing pharmaceutical R&D, and stringent safety regulations. Innovations in alternative testing methods and ethical considerations are shaping market dynamics, promoting the development of more predictive and humane testing approaches.

Market Overview:

The In Vivo Toxicology Market is experiencing robust expansion, primarily driven by the pharmaceutical and biotechnology sectors' increasing demand for preclinical testing. The rodent-based segment dominates the market, largely due to its extensive use in toxicity testing and the availability of well-established protocols. Rodents, particularly mice and rats, are preferred due to their genetic similarities to humans and the wealth of historical data supporting their use. This segment's dominance is further reinforced by regulatory requirements mandating animal testing for drug approval processes. Emerging sub-segments, such as zebrafish and non-mammalian models, are gaining attention due to their cost-effectiveness and ethical advantages. These sub-segments offer rapid developmental insights and high-throughput screening capabilities, potentially transforming early-stage drug discovery and environmental toxicity assessments. As technological advancements continue to enhance the precision and ethical considerations of in vivo testing, these emerging models are poised to significantly impact the market landscape, fostering innovation and expanding applications.

Market Segmentation
TypeAcute Toxicity Testing, Chronic Toxicity Testing, Sub-chronic Toxicity Testing, Developmental and Reproductive Toxicity Testing, Carcinogenicity Testing
ProductInstruments, Animal Models, Reagents and Kits
ServicesConsulting Services, Preclinical Testing Services
TechnologyCRISPR, RNA Interference, High-Throughput Screening
ComponentSoftware, Hardware
ApplicationPharmaceuticals, Biotechnology, Cosmetics, Food Industry, Chemical Industry
Material TypeBiologicals, Chemicals
End UserResearch Institutes, Contract Research Organizations, Pharmaceutical Companies, Biotechnology Companies
StageDiscovery, Preclinical, Clinical, Post-market Surveillance

The in vivo toxicology market is predominantly influenced by the pharmaceutical and biotechnology sectors, with significant contributions from chemical and food industries. This landscape is shaped by the increasing demand for comprehensive safety assessments and regulatory compliance. North America maintains a leading position due to its advanced research infrastructure and regulatory frameworks, while Asia-Pacific is witnessing substantial growth fueled by rising investments in drug development and innovation. Major industry players are enhancing their market presence through strategic collaborations and technological advancements in testing methodologies. Competitive dynamics are influenced by stringent regulatory requirements and the pursuit of alternative testing methods to reduce animal use. Companies are focusing on the development of more predictive and humane toxicological models, spurred by regulatory agencies like the FDA and EMA advocating for such innovations. The future trajectory of the market appears promising, with advancements in technologies such as CRISPR and organ-on-a-chip expected to revolutionize traditional testing paradigms. However, challenges such as ethical concerns and the high cost of advanced technologies remain, necessitating ongoing innovation and investment.

Geographical Overview:

The In Vivo Toxicology Market is witnessing varied growth patterns across different regions. North America leads the market with advanced research facilities and substantial funding for toxicological studies. The presence of key pharmaceutical companies further propels market growth. Europe follows, characterized by stringent regulatory frameworks that necessitate comprehensive in vivo testing. These regulations drive demand for innovative toxicology solutions. In Asia Pacific, rapid industrialization and increasing pharmaceutical activities contribute to market expansion. The region's focus on improving healthcare infrastructure also plays a crucial role. Latin America and the Middle East & Africa show emerging potential, with growing awareness of in vivo testing's importance. In Latin America, government initiatives to enhance research capabilities are notable. Meanwhile, the Middle East & Africa are investing in healthcare advancements, recognizing the value of in vivo toxicology in ensuring drug safety and efficacy.

Recent Developments:

In recent months, the In Vivo Toxicology Market has witnessed several noteworthy developments. Firstly, Charles River Laboratories announced a strategic acquisition of a European-based toxicology services provider, aiming to enhance its global service capabilities. Secondly, a significant partnership between Covance and a leading biotech firm was established to co-develop advanced in vivo toxicology testing methods, promising to expedite drug development timelines. Thirdly, the market saw an innovative product launch by Envigo, introducing a new line of genetically engineered animal models designed to improve the accuracy of toxicological assessments. Additionally, the sector experienced regulatory updates, with the FDA releasing new guidelines to streamline the approval process for in vivo toxicology testing protocols, thereby potentially reducing time-to-market for new pharmaceuticals. Lastly, a notable investment was made by a consortium of venture capital firms into a startup specializing in AI-driven in vivo toxicology analytics, highlighting the growing interest in integrating cutting-edge technology to enhance research outcomes.

Key Trends and Drivers:

The in vivo toxicology market is experiencing growth fueled by advancements in biotechnology and pharmaceutical research. A key trend is the increased emphasis on precision medicine, which necessitates comprehensive toxicological assessments to ensure the safety of tailored therapies. Regulatory bodies are intensifying their scrutiny, driving demand for more rigorous in vivo testing protocols. Emerging technologies, such as CRISPR and advanced imaging techniques, are enhancing the accuracy and efficiency of toxicological studies. These innovations are reducing the time and cost associated with drug development, creating lucrative opportunities for market players. The rise in chronic diseases and the consequent surge in drug discovery initiatives are substantial drivers for this market. Furthermore, there is a growing focus on alternative methods that reduce animal testing, aligning with ethical standards and public sentiment. This includes the development of sophisticated in vitro models that complement in vivo studies. Companies investing in these areas are likely to gain competitive advantages. The increasing global investment in healthcare infrastructure and research is further propelling market expansion, particularly in developing regions where healthcare modernization is a priority.

Restraints and Challenges:

The in vivo toxicology market encounters several prominent restraints and challenges. One significant challenge is the ethical concerns surrounding animal testing, which has led to increased regulatory scrutiny and the development of alternative testing methods. This shift necessitates substantial investment in research and adaptation, posing a barrier for smaller enterprises. Additionally, the high cost of in vivo studies, due to the need for specialized facilities and skilled personnel, limits accessibility for emerging markets and smaller companies. The complexity of biological systems further complicates the interpretation of results, requiring advanced expertise and potentially leading to inconsistent outcomes. Moreover, stringent regulatory requirements across different regions can delay product approvals and increase compliance costs. Finally, there is a growing demand for more predictive and human-relevant models, which challenges traditional in vivo methodologies and requires ongoing innovation and validation efforts. These factors collectively impede the rapid progression of the in vivo toxicology market.

Key Companies:

Charles River Laboratories, Envigo, Taconic Biosciences, Harlan Laboratories, Genoway, Crown Bioscience, The Jackson Laboratory, Trans Cure bio Services, Inotiv, Biomere, Vivo Bio Tech, Pharmaron, Syngene International, Labcorp Drug Development, Wu Xi App Tec, Cyagen Biosciences, Chem Partner, Eurofins Scientific, Toxikon, Biocytogen

Sources:

U.S. Food and Drug Administration, European Medicines Agency, National Institutes of Health (NIH), World Health Organization, Organisation for Economic Co-operation and Development (OECD) - Chemicals and Biotechnology, U.S. Environmental Protection Agency - Toxicology, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Society of Toxicology, National Toxicology Program, European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), International Union of Toxicology, Johns Hopkins University Center for Alternatives to Animal Testing, University of California, Davis - School of Veterinary Medicine, Harvard University - Department of Environmental Health, International Conference on Toxicology and Risk Assessment, Society for In Vitro Biology, European Society of Toxicology In Vitro, American College of Toxicology Annual Meeting, International Conference on Environmental Toxicology and Pharmacology, World Congress on Alternatives and Animal Use in the Life Sciences

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: In Vivo Toxicology Market Overview

  • 1.1 Objectives of the Study
  • 1.2 In Vivo Toxicology Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by Material Type
  • 2.10 Key Highlights of the Market, by End User
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by Material Type
  • 3.9 Market Attractiveness Analysis, by End User
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: In Vivo Toxicology Market Outlook

  • 4.1 In Vivo Toxicology Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: In Vivo Toxicology In Vivo Toxicology Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: In Vivo Toxicology Market Size

  • 6.1 In Vivo Toxicology Market Size, by Value
  • 6.2 In Vivo Toxicology Market Size, by Volume

7: In Vivo Toxicology Market, by Type

  • 7.1 Market Overview
  • 7.2 Acute Toxicity Testing
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Chronic Toxicity Testing
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Sub-chronic Toxicity Testing
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Developmental and Reproductive Toxicity Testing
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Carcinogenicity Testing
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Others
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region

8: In Vivo Toxicology Market, by Product

  • 8.1 Market Overview
  • 8.2 Instruments
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Animal Models
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Reagents and Kits
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: In Vivo Toxicology Market, by Services

  • 9.1 Market Overview
  • 9.2 Consulting Services
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Preclinical Testing Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Others
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region

10: In Vivo Toxicology Market, by Technology

  • 10.1 Market Overview
  • 10.2 CRISPR
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 RNA Interference
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 High-Throughput Screening
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: In Vivo Toxicology Market, by Component

  • 11.1 Market Overview
  • 11.2 Software
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Hardware
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Others
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region

12: In Vivo Toxicology Market, by Application

  • 12.1 Market Overview
  • 12.2 Pharmaceuticals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Cosmetics
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Food Industry
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Chemical Industry
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: In Vivo Toxicology Market, by Material Type

  • 13.1 Market Overview
  • 13.2 Biologicals
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Chemicals
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: In Vivo Toxicology Market, by End User

  • 14.1 Market Overview
  • 14.2 Research Institutes
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Contract Research Organizations
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Pharmaceutical Companies
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Biotechnology Companies
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: In Vivo Toxicology Market, by Stage

  • 15.1 Market Overview
  • 15.2 Discovery
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Preclinical
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Clinical
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Post-market Surveillance
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Others
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region

16: In Vivo Toxicology Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Component
    • 16.2.7 North America Market Size and Forecast, by Application
    • 16.2.8 North America Market Size and Forecast, by Material Type
    • 16.2.9 North America Market Size and Forecast, by End User
    • 16.2.10 North America Market Size and Forecast, by Stage
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Component
      • 16.2.9.6 United States Market Size and Forecast, by Application
      • 16.2.9.7 United States Market Size and Forecast, by Material Type
      • 16.2.9.8 United States Market Size and Forecast, by End User
      • 16.2.9.9 United States Market Size and Forecast, by Stage
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Component
      • 16.2.10.6 Canada Market Size and Forecast, by Application
      • 16.2.10.7 Canada Market Size and Forecast, by Material Type
      • 16.2.10.8 Canada Market Size and Forecast, by End User
      • 16.2.10.9 Canada Market Size and Forecast, by Stage
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Component
    • 16.3.7 Europe Market Size and Forecast, by Application
    • 16.3.8 Europe Market Size and Forecast, by Material Type
    • 16.3.9 Europe Market Size and Forecast, by End User
    • 16.3.10 Europe Market Size and Forecast, by Stage
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Material Type
      • 16.3.9.8 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Component
      • 16.3.10.6 Germany Market Size and Forecast, by Application
      • 16.3.10.7 Germany Market Size and Forecast, by Material Type
      • 16.3.10.8 Germany Market Size and Forecast, by End User
      • 16.3.10.9 Germany Market Size and Forecast, by Stage
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Component
      • 16.3.11.6 France Market Size and Forecast, by Application
      • 16.3.11.7 France Market Size and Forecast, by Material Type
      • 16.3.11.8 France Market Size and Forecast, by End User
      • 16.3.11.9 France Market Size and Forecast, by Stage
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Component
      • 16.3.12.6 Spain Market Size and Forecast, by Application
      • 16.3.12.7 Spain Market Size and Forecast, by Material Type
      • 16.3.12.8 Spain Market Size and Forecast, by End User
      • 16.3.12.9 Spain Market Size and Forecast, by Stage
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Component
      • 16.3.13.6 Italy Market Size and Forecast, by Application
      • 16.3.13.7 Italy Market Size and Forecast, by Material Type
      • 16.3.13.8 Italy Market Size and Forecast, by End User
      • 16.3.13.9 Italy Market Size and Forecast, by Stage
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Component
      • 16.3.14.6 Netherlands Market Size and Forecast, by Application
      • 16.3.14.7 Netherlands Market Size and Forecast, by Material Type
      • 16.3.14.8 Netherlands Market Size and Forecast, by End User
      • 16.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Component
      • 16.3.15.6 Sweden Market Size and Forecast, by Application
      • 16.3.15.7 Sweden Market Size and Forecast, by Material Type
      • 16.3.15.8 Sweden Market Size and Forecast, by End User
      • 16.3.15.9 Sweden Market Size and Forecast, by Stage
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Component
      • 16.3.16.6 Switzerland Market Size and Forecast, by Application
      • 16.3.16.7 Switzerland Market Size and Forecast, by Material Type
      • 16.3.16.8 Switzerland Market Size and Forecast, by End User
      • 16.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Component
      • 16.3.17.6 Denmark Market Size and Forecast, by Application
      • 16.3.17.7 Denmark Market Size and Forecast, by Material Type
      • 16.3.17.8 Denmark Market Size and Forecast, by End User
      • 16.3.17.9 Denmark Market Size and Forecast, by Stage
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Component
      • 16.3.18.6 Finland Market Size and Forecast, by Application
      • 16.3.18.7 Finland Market Size and Forecast, by Material Type
      • 16.3.18.8 Finland Market Size and Forecast, by End User
      • 16.3.18.9 Finland Market Size and Forecast, by Stage
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Component
      • 16.3.19.6 Russia Market Size and Forecast, by Application
      • 16.3.19.7 Russia Market Size and Forecast, by Material Type
      • 16.3.19.8 Russia Market Size and Forecast, by End User
      • 16.3.19.9 Russia Market Size and Forecast, by Stage
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Material Type
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Material Type
    • 16.4.9 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Component
      • 16.4.9.6 China Market Size and Forecast, by Application
      • 16.4.9.7 China Market Size and Forecast, by Material Type
      • 16.4.9.8 China Market Size and Forecast, by End User
      • 16.4.9.9 China Market Size and Forecast, by Stage
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Component
      • 16.4.10.6 India Market Size and Forecast, by Application
      • 16.4.10.7 India Market Size and Forecast, by Material Type
      • 16.4.10.8 India Market Size and Forecast, by End User
      • 16.4.10.9 India Market Size and Forecast, by Stage
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Component
      • 16.4.11.6 Japan Market Size and Forecast, by Application
      • 16.4.11.7 Japan Market Size and Forecast, by Material Type
      • 16.4.11.8 Japan Market Size and Forecast, by End User
      • 16.4.11.9 Japan Market Size and Forecast, by Stage
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Component
      • 16.4.12.6 South Korea Market Size and Forecast, by Application
      • 16.4.12.7 South Korea Market Size and Forecast, by Material Type
      • 16.4.12.8 South Korea Market Size and Forecast, by End User
      • 16.4.12.9 South Korea Market Size and Forecast, by Stage
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Component
      • 16.4.13.6 Australia Market Size and Forecast, by Application
      • 16.4.13.7 Australia Market Size and Forecast, by Material Type
      • 16.4.13.8 Australia Market Size and Forecast, by End User
      • 16.4.13.9 Australia Market Size and Forecast, by Stage
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Component
      • 16.4.14.6 Singapore Market Size and Forecast, by Application
      • 16.4.14.7 Singapore Market Size and Forecast, by Material Type
      • 16.4.14.8 Singapore Market Size and Forecast, by End User
      • 16.4.14.9 Singapore Market Size and Forecast, by Stage
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Component
      • 16.4.15.6 Indonesia Market Size and Forecast, by Application
      • 16.4.15.7 Indonesia Market Size and Forecast, by Material Type
      • 16.4.15.8 Indonesia Market Size and Forecast, by End User
      • 16.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Component
      • 16.4.16.6 Taiwan Market Size and Forecast, by Application
      • 16.4.16.7 Taiwan Market Size and Forecast, by Material Type
      • 16.4.16.8 Taiwan Market Size and Forecast, by End User
      • 16.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Component
      • 16.4.17.6 Malaysia Market Size and Forecast, by Application
      • 16.4.17.7 Malaysia Market Size and Forecast, by Material Type
      • 16.4.17.8 Malaysia Market Size and Forecast, by End User
      • 16.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Component
    • 16.5.7 Latin America Market Size and Forecast, by Application
    • 16.5.8 Latin America Market Size and Forecast, by Material Type
    • 16.5.9 Latin America Market Size and Forecast, by End User
    • 16.5.10 Latin America Market Size and Forecast, by Stage
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Component
      • 16.5.9.6 Brazil Market Size and Forecast, by Application
      • 16.5.9.7 Brazil Market Size and Forecast, by Material Type
      • 16.5.9.8 Brazil Market Size and Forecast, by End User
      • 16.5.9.9 Brazil Market Size and Forecast, by Stage
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Component
      • 16.5.10.6 Mexico Market Size and Forecast, by Application
      • 16.5.10.7 Mexico Market Size and Forecast, by Material Type
      • 16.5.10.8 Mexico Market Size and Forecast, by End User
      • 16.5.10.9 Mexico Market Size and Forecast, by Stage
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Component
      • 16.5.11.6 Argentina Market Size and Forecast, by Application
      • 16.5.11.7 Argentina Market Size and Forecast, by Material Type
      • 16.5.11.8 Argentina Market Size and Forecast, by End User
      • 16.5.11.9 Argentina Market Size and Forecast, by Stage
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Material Type
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Material Type
    • 16.6.9 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Material Type
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Component
      • 16.6.10.6 UAE Market Size and Forecast, by Application
      • 16.6.10.7 UAE Market Size and Forecast, by Material Type
      • 16.6.10.8 UAE Market Size and Forecast, by End User
      • 16.6.10.9 UAE Market Size and Forecast, by Stage
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Component
      • 16.6.11.6 South Africa Market Size and Forecast, by Application
      • 16.6.11.7 South Africa Market Size and Forecast, by Material Type
      • 16.6.11.8 South Africa Market Size and Forecast, by End User
      • 16.6.11.9 South Africa Market Size and Forecast, by Stage
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Material Type
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Charles River Laboratories
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Envigo
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Taconic Biosciences
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Harlan Laboratories
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Genoway
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Crown Bioscience
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 The Jackson Laboratory
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 TransCure bioServices
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Inotiv
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Biomere
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Vivo Bio Tech
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Pharmaron
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Syngene International
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Labcorp Drug Development
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 WuXi AppTec
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
  • 18.16 Cyagen Biosciences
    • 18.16.1 Company Overview
    • 18.16.2 Company Snapshot
    • 18.16.3 Business Segments
    • 18.16.4 Business Performance
    • 18.16.5 Product Offerings
    • 18.16.6 Key Developmental Strategies
    • 18.16.7 SWOT Analysis
  • 18.17 ChemPartner
    • 18.17.1 Company Overview
    • 18.17.2 Company Snapshot
    • 18.17.3 Business Segments
    • 18.17.4 Business Performance
    • 18.17.5 Product Offerings
    • 18.17.6 Key Developmental Strategies
    • 18.17.7 SWOT Analysis
  • 18.18 Eurofins Scientific
    • 18.18.1 Company Overview
    • 18.18.2 Company Snapshot
    • 18.18.3 Business Segments
    • 18.18.4 Business Performance
    • 18.18.5 Product Offerings
    • 18.18.6 Key Developmental Strategies
    • 18.18.7 SWOT Analysis
  • 18.19 Toxikon
    • 18.19.1 Company Overview
    • 18.19.2 Company Snapshot
    • 18.19.3 Business Segments
    • 18.19.4 Business Performance
    • 18.19.5 Product Offerings
    • 18.19.6 Key Developmental Strategies
    • 18.19.7 SWOT Analysis
  • 18.20 Biocytogen
    • 18.20.1 Company Overview
    • 18.20.2 Company Snapshot
    • 18.20.3 Business Segments
    • 18.20.4 Business Performance
    • 18.20.5 Product Offerings
    • 18.20.6 Key Developmental Strategies
    • 18.20.7 SWOT Analysis